共 264 条
[1]
Wallin MT(2019)The prevalence of MS in the United States: a population-based estimate using health claims data Neurology 92 e1029-e1040
[2]
Culpepper WJ(2022)The economic burden of multiple sclerosis in the United States: estimate of direct and indirect costs Neurology 98 e1810-e1817
[3]
Campbell JD(2019)Clinical outcomes of escalation vs early intensive disease-modifying therapy in patients with multiple sclerosis JAMA Neurol 76 536-541
[4]
Nelson LM(2020)Initial high-efficacy disease-modifying therapy in multiple sclerosis: a nationwide cohort study Neurology 95 e1041-e1051
[5]
Langer-Gould A(2020)Race and ethnicity on MS presentation and disease course Mult Scler 26 561-567
[6]
Marrie RA(2021)How multiple sclerosis symptoms vary by age, sex, and race/ethnicity Neurol Clin Pract. 11 335-341
[7]
Bebo B(2011)Multiple sclerosis in Hispanics: a study of clinical disease expression Mult Scler 17 1010-1016
[8]
Cintina I(2017)Hispanic Americans and African Americans with multiple sclerosis have more severe disease course than Caucasian Americans Mult Scler 23 1554-1557
[9]
LaRocca N(2003)Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium Mult Scler 9 293-298
[10]
Ritter L(2006)Does multiple sclerosis–associated disability differ between races? Neurology 66 1235-1240